IOVANCE BIOTHERAPEUTICS, INC. Shareholders' Equity
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) had Shareholders' Equity of $736.04 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-06
- 2026-06-30: Stockholders' Equity Attributable to Parent $736.04M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $721.75M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $698.58M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $702.29M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $736.04M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $721.75M 10-Q · filed 2026-08-06 | |
| 2025-12-31 | $698.58M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $702.29M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $698.49M 10-Q · filed 2026-08-06 | |
| 2025-03-31 | $767.87M 10-Q · filed 2026-08-06 | |
| 2024-12-31 | $710.40M 10-Q · filed 2026-08-06 | |
| 2024-09-30 | $773.46M 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $768.54M 10-Q · filed 2025-11-06 | |
| 2024-03-31 | $680.02M 10-Q · filed 2025-08-07 | |
| 2023-12-31 | $584.61M 10-K · filed 2026-02-24 | |
| 2023-09-30 | $674.01M 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $578.57M 10-Q · filed 2024-11-07 | |
| 2023-03-31 | $666.88M 10-Q · filed 2024-08-08 | |
| 2022-12-31 | $499.64M 10-K · filed 2026-02-24 | |
| 2022-09-30 | $393.74M 10-Q · filed 2023-11-07 | |
| 2022-06-30 | $472.69M 10-Q · filed 2023-11-07 | |
| 2022-03-31 | $551.99M 10-Q · filed 2023-08-08 | |
| 2021-12-31 | $621.66M 10-K · filed 2025-02-27 | |
| 2021-09-30 | $698.33M 10-Q · filed 2022-11-03 | |
| 2021-06-30 | $744.41M 10-Q · filed 2022-11-03 | |
| 2021-03-31 | $647.43M 10-Q · filed 2022-08-04 | |
| 2020-12-31 | $656.50M 10-K · filed 2024-02-28 | |
| 2020-09-30 | $711.84M 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $758.31M 10-Q · filed 2021-11-04 | |
| 2020-03-31 | $243.31M 10-Q · filed 2021-08-05 | |
| 2019-12-31 | $298.97M 10-K · filed 2023-02-28 | |
| 2019-09-30 | $355.06M 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $397.42M 10-Q · filed 2020-11-05 | |
| 2019-03-31 | $434.93M 10-Q · filed 2020-08-06 | |
| 2018-12-31 | $466.19M 10-K · filed 2022-02-24 | |
| 2018-09-30 | $254.16M 10-Q · filed 2019-11-04 | |
| 2018-06-30 | $270.57M 10-Q · filed 2019-11-04 | |
| 2018-03-31 | $292.56M 10-Q · filed 2019-08-01 | |
| 2017-12-31 | $145.48M 10-K · filed 2021-02-25 | |
| 2017-09-30 | $165.44M 10-Q · filed 2017-11-02 | |
| 2017-06-30 | $129.15M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $149.89M 10-Q · filed 2017-05-03 | |
| 2016-12-31 | $166.92M 10-K · filed 2020-02-25 | |
| 2016-09-30 | $179.13M 10-Q · filed 2016-11-04 | |
| 2016-06-30 | $188.94M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $98.94M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $104.02M 10-K · filed 2019-02-28 | |
| 2015-09-30 | $109.37M 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $112.87M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $111.63M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $44.84M 10-K · filed 2018-03-12 | $44.85M 10-K · filed 2015-03-16 |
| 2014-09-30 | $16.16M 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $17.38M 10-Q · filed 2014-08-08 | |
| 2014-03-31 | $16.81M 10-Q · filed 2014-05-14 | |
| 2013-12-31 | $17.60M 10-K · filed 2017-03-09 | $17.60M 10-K · filed 2014-03-28 |
| 2013-09-30 | -$3.34M 10-Q · filed 2013-11-14 | |
| 2013-06-30 | -$2.77M 10-Q · filed 2013-10-23 | |
| 2013-03-31 | -$12.28M 10-Q · filed 2013-10-23 | |
| 2012-12-31 | -$11.32M 10-K · filed 2016-03-11 | -$11.32M 10-K · filed 2013-09-23 |
| 2012-09-30 | -$16.58M 10-Q · filed 2013-01-25 | |
| 2012-06-30 | -$16.62M 10-Q/A · filed 2012-09-10 | |
| 2012-03-31 | -$17.26M 10-Q · filed 2012-05-15 | |
| 2011-12-31 | -$12.78M 10-K · filed 2014-03-28 | |
| 2011-09-30 | -$5.69M 10-Q · filed 2011-11-21 | |
| 2011-06-30 | -$1.40M 10-Q/A · filed 2011-09-01 | |
| 2010-12-31 | $638.09K 10-K · filed 2014-03-28 | |
| 2009-12-31 | -$13.49K 10-K · filed 2014-03-28 | |
| 2008-12-31 | $2.28K 10-K · filed 2014-03-28 | |
| 2007-12-31 | $61.00K 10-K · filed 2013-09-23 | |
| 2007-09-16 | $8.00K 10-K · filed 2014-03-28 | $0.00 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |